Literature DB >> 11005258

Enhanced CD9 expression in the mouse and human brains infected with transmissible spongiform encephalopathies.

K Doh-ura1, E Mekada, K Ogomori, T Iwaki.   

Abstract

A tetraspan protein CD9, normally expressed in the myelin sheath of the central and peripheral nervous system, was identified to be up-regulated in mouse brains infected with transmissible spongiform encephalopathy (TSE), by mRNA differential display screening. To elucidate its role in the neurodegeneration process observed in TSE, CD9 expression was examined in the murine disease model and in the human disease materials. Up-regulation of CD9 gene expression in the TSE-infected mouse brains was detected as early as a preclinical stage, when abnormal prion protein deposition and vacuolation were obviously manifested in the internal capsule and thalamus. In contrast, other myelin protein genes showed a reverse pattern of CD9 gene expression. Enhanced CD9 expression was immunohistochemically detected in the astrocytes of such pathological regions. In human specimens of TSE, enhanced CD9 immunoreactivity was observed in the astrocytes and some oligodendrocytes in the brains, but no relevant alteration in CD9 immunoreactivity was observed in the other organs or tissues. Positive CD9 immunoreactivity in astrocytes was also manifest in other neurological disorders in a less prominent manner. The findings indicate that up-regulated CD9 plays a role in glial cells in pathological conditions, especially in such a devastating condition as TSE.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005258     DOI: 10.1093/jnen/59.9.774

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  11 in total

1.  Outcome of array CGH analysis for 255 subjects with intellectual disability and search for candidate genes using bioinformatics.

Authors:  Y Qiao; C Harvard; C Tyson; X Liu; C Fawcett; P Pavlidis; J J A Holden; M E S Lewis; E Rajcan-Separovic
Journal:  Hum Genet       Date:  2010-05-29       Impact factor: 4.132

2.  Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner.

Authors:  Yuri Kawasaki; Keiichi Kawagoe; Chun-jen Chen; Kenta Teruya; Yuji Sakasegawa; Katsumi Doh-ura
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

3.  Toxicity of quinacrine can be reduced by co-administration of P-glycoprotein inhibitor in sporadic Creutzfeldt-Jakob disease.

Authors:  Katsuya Satoh; Susumu Shirabe; Katsumi Eguchi; Atsushi Yamauchi; Yasufumi Kataoka; Masami Niwa; Noriyuki Nishida; Shigeru Katamine
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

4.  Treatment of transmissible spongiform encephalopathy by intraventricular drug infusion in animal models.

Authors:  Katsumi Doh-ura; Kensuke Ishikawa; Ikuko Murakami-Kubo; Kensuke Sasaki; Shirou Mohri; Richard Race; Toru Iwaki
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Quinoline derivatives are therapeutic candidates for transmissible spongiform encephalopathies.

Authors:  Ikuko Murakami-Kubo; Katsumi Doh-Ura; Kensuke Ishikawa; Satoshi Kawatake; Kensuke Sasaki; Jun-Ichi Kira; Shigeru Ohta; Toru Iwaki
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Genes contributing to prion pathogenesis.

Authors:  Gültekin Tamgüney; Kurt Giles; David V Glidden; Pierre Lessard; Holger Wille; Patrick Tremblay; Darlene F Groth; Fruma Yehiely; Carsten Korth; Richard C Moore; Jörg Tatzelt; Eric Rubinstein; Claude Boucheix; Xiaoping Yang; Pamela Stanley; Michael P Lisanti; Raymond A Dwek; Pauline M Rudd; Jackob Moskovitz; Charles J Epstein; Tracey Dawson Cruz; William A Kuziel; Nobuyo Maeda; Jan Sap; Karen Hsiao Ashe; George A Carlson; Ina Tesseur; Tony Wyss-Coray; Lennart Mucke; Karl H Weisgraber; Robert W Mahley; Fred E Cohen; Stanley B Prusiner
Journal:  J Gen Virol       Date:  2008-07       Impact factor: 3.891

7.  Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy.

Authors:  Yue Tang; Wei Xiang; Linda Terry; Hans A Kretzschmar; Otto Windl
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

8.  Prion disease induced alterations in gene expression in spleen and brain prior to clinical symptoms.

Authors:  Hyeon O Kim; Greg P Snyder; Tyler M Blazey; Richard E Race; Bruce Chesebro; Pamela J Skinner
Journal:  Adv Appl Bioinform Chem       Date:  2008-09-07

Review 9.  Strategies for targeting tetraspanin proteins: potential therapeutic applications in microbial infections.

Authors:  Noha Hassuna; Peter N Monk; Gregory W Moseley; Lynda J Partridge
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

Review 10.  Tetraspanins as Potential Modulators of Glutamatergic Synaptic Function.

Authors:  Amina Becic; Jennifer Leifeld; Javeria Shaukat; Michael Hollmann
Journal:  Front Mol Neurosci       Date:  2022-01-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.